Choosing the best strain for your medicine
It is our pleasure to present you three new hemp-strains in spring 2016, which exhibit no psycho-active effects. This is ensured by a high cannabidiol (CBD) content with only trace amounts of tetrahydrocannabinol (Δ9-THC <0.9%).
As pioneers regarding the introduction of medicinal hemp into medical therapies, it is our main focus to guarantee an uncomplicated and reliable treatment to patients suffering from various afflictions.
The therapy with medical Hemp, which does not show psychoactive properties, has only little side effects. It offers therefore an excellent alternative to conventional medicine. Its impact helps to reduce ailments regarding a multitude of diseases verifiably.
Medropharm LLC is engaged in promoting the understanding and acceptance of the numerous potential benefits of medical Cannabis.
In order to meet the various needs of our patients we deliver high quality strains grown in Switzerland and traded to justifiable prices.
Our team includes experienced leaders in the fields of molecular plant genetics, biotechnology, horticulture and quality assurance.
Our facility is designed to meet the high standards of the medical cannabis industry and we operate under strict quality assurance. This begins at the selection of seeds and is maintained throughout all stages of the product lifecycle.
We will keep you informed as the process continues. Hence, please check this page for updates.
Posted by medropharm on 2016-06-12 12:36:18
Tagged: , Hanf Forschung , Cannabis , Cannabis Company , CBD , CBD Produkte , Cannabis Forschung , Cannabis Sativa , Hanfpulver , Hemp , Hanffood , Medropharm , Medical Marihuana , Medical Cannabis , Medizin , Medinzisches Cannabis , Krankheit , Gesundheit , Genetik , Medropharm-M-1337 , EU-zertified Industrial hemp , Marijuana News , Marjhuana News , Swiss Cannabis Company , Swiss made